Faculty Scholarship

Center for Health & Pharmaceutical Law & Policy

Health and Pharmaceutical

Professor Kathleen Boozang, The Aspirations and Challenges of Decision Aids, Arizona Syllabus (Spring 2013)

Professor Kathleen Boozang, Annual Flora Barlotta Lecture: End of Life Care, (Spring 2011) (Saint Barnabas Medical Center)

Professor Kathleen Boozang, U.S. Waste Fraud and Abuse Laws, E.U. Corporate Compliance Program (June 2011) (Paris, France)

Professor Kate Greenwood, An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, J. Health & Life Sci. L., 230-267 (June 2011) (with Kathleen M. Boozang and Carl H. Coleman)

Professor Carl Coleman, An Argument against Embedding Conflicts of Interest Disclosures in Informed Consent, J. Health & Life Sciences L., 230-267 (June 2011) (with Kathleen M. Boozang and Kate Greenwood)

Professor Kate Greenwood, The Alternate Approach to Medicinal Marijuana Distribution, The Record, O-1 (July 25, 2010)

Professor Carl Coleman, The Role of Informed Consent in Turberculosis Testing and Screening, 39 European Respiratory J. 1057-59 (forthcoming 2012) (with Michael Selgelid, Andreas Reis, Lee Reichman, and Ernesto Jaramillo)

Professor Kate Greenwood, "Litigant Regulation" of Physician Conflicts of Interest, Ga. St. U. L. Rev. (forthcoming)

Professor Kate Greenwood, Medical Affairs: Effectively and Legitimately Using Medical Science Liaisons, Off-Label Communications: A Guide to Sales & Marketing Compliance (Food and Drug Law Institute 3rd Ed. 2012) (with Bruce D. Armon)
View Professor Greenwood's Bio

Professor Kate Greenwood, Toward Evidence-Based Conflicts of Interest Training for Physician-Investigators, J.L. Med. & Ethics, 500-507 (Fall 2012) (with Kathleen M. Boozang and Carl H. Coleman)

Professor John Jacobi, Medicaid Evolution for the 21st Century, __Kentucky L. J. __ (2013) (in press)

Professor Kathleen Boozang, Symposium: Is a For-Profit Structure a Viable Alternative for a Health Care Ministry?, Center for Religiously Affiliated Nonprofit Corporations & Center for Health & Pharmaceutical Law & Policy (2013) (In collaboration with University of St. Thomas)

Professor Kathleen Boozang, Transparency: It May Not Be Sufficient, 4 Life Science Compliance 14 (2012)

Professor Kathleen Boozang, The New Relator: In-House Counsel and Compliance Officers, J. H & Life Sciences L. (2012)

Professor John Jacobi, Active or Passive: The Role of a New Jersey Health Insurance Exchange, Rutgers Center for State Health Policy and Seton Hall Center for Health & Pharmaceutical Law & Policy (2012)

Professor John Jacobi, Implementing the Essential Health Benefits Requirement in New Jersey: Decision Points and Policy Issues, Rutgers Center for State Health Policy & Center for Health & Pharmaceutical Law & Policy (2012) (with Tara Ragone, Kate Greenwood and John Jacobi)

Professor Kate Greenwood, Implementing the Essential Health Benefits Requirement in New Jersey: Decision Points and Policy Issues, policy brief issued by the Center for Health & Pharmaceutical Law & Policy & the Rutgers Center for State Health Policy (2012) (with John V. Jacobi and Tara Adams Ragone)

Professor Kate Greenwood, The Affordable Care Act’s Risk Adjustment and Other Risk-Spreading Mechanisms: Needed Support for New Jersey’s Health Insurance Exchange, policy brief issued by the Center for Health & Pharmaceutical Law & Policy and the Rutgers Center for State Health Policy (2012)

Professor Kate Greenwood, The Health Insurance Exchange, the Medicaid Program, and the Apportionment of Responsibility for Determining Eligibility and Effectuating Enrollment in New Jersey, policy brief issued by the Center for Health & Pharmaceutical Law & Policy and the Rutgers Center for State Health Policy (2012)

Professor Carl Coleman, End-of-Life Treatment Decisions in United States Law, in Stefania Negri ed., Self-Determination, Dignity and End-of-Life Care: Regulating Advance Directives in International and Comparative Perspective (2012)

Professor Carl Coleman, Do Physicians' Legal Duties to Patients Conflict with Public Health Values? The Case of Antibiotic Overprescription, in in Michael J. Selgelid et. al. eds., Infectious Disease Ethics: Limiting Liberty in Contexts of Contagion (2011)

Professor Kathleen Boozang, An Argument Against Embedding Conflicts of Interest Disclosures in Informed Consent, 4 J.H. & Life Sciences L. 230 (2011) (with Carl H. Coleman and Kate Greenwood)

Professor Kate Greenwood, The Ban on "Off-Label" Pharmaceutical Promotion: Constitutionally Permissible Prophylaxis against False or Misleading Commercial Speech?, 37 AM. J. L. & Med. 278 (2011) (symposium)

Professor John Jacobi, High Utilizers of ED Services: Lessons for System Reform, 20 Annals of Health Law 35 (2011)

Professor John Jacobi, Implementing Health Reform at the State Level: Access and Care for Vulnerable Populations, 39 J. Law, Medicine & Ethics 69 (2011) (with Watson and Restuccia)

Professor John Jacobi, Health Insurance Exchanges: Governance Issues for New Jersey, Rutgers Center for State Health Policy and Seton Hall Center for Health & Pharmaceutical Law & Policy (2011)

Professor Kate Greenwood, The Limits of Disclosure as a Response to Financial Conflicts of Interest in Clinical Research, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2010) (collaborator)

Professor Kate Greenwood, The Mysteries of Pregnancy: The Role of Law in Solving the Problem of Unknown but Knowable Maternal-Fetal Medication Risk, 79 U. Cin. L. Rev. 267 (2010)

Professor Kate Greenwood, Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Professor Kate Greenwood, Drug and Device Promotion: Charting A Course for Policy Reform, white paper issued by the Center for Health & Pharmaceutical Law & Policy (2009) (collaborator)

Professor John Jacobi, Prison Health, Public Health: Obligations and Opportunities, , 31 Am. J. Law & Medicine 447 (2005)

Professor John Jacobi, Quality Control, Enterprise Liability, and Disintermediation in Managed Care, 29 J. Law Medicine & Ethics 305 (2001) (with N. Huberfeld)